A Practical Guide for Using Registry Data to Inform Decisions About the Cost Effectiveness of New Cancer Drugs: Lessons Learned from the PHAROS Registry

Decision makers increasingly request evidence on the real-world cost effectiveness of a new treatment. There is, however, a lack of practical guidance on how to conduct an economic evaluation based on registry data and how this evidence can be used in actual decision making. This paper explains the...

Descripción completa

Detalles Bibliográficos
Autores principales: Blommestein, Hedwig M., Franken, Margreet G., Uyl-de Groot, Carin A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Practical Application
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4445765/
https://www.ncbi.nlm.nih.gov/pubmed/25644460
http://dx.doi.org/10.1007/s40273-015-0260-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4445765/
https://www.ncbi.nlm.nih.gov/pubmed/25644460
http://dx.doi.org/10.1007/s40273-015-0260-4

Ejemplares similares